Skip to Content

AllerNaze Approval History

FDA Approved: Yes (First approved January 7, 2009)
Brand name: AllerNaze
Generic name: triamcinolone acetonide
Dosage form: Nasal Spray
Previous Name: AllerNase
Company: Collegium Pharmaceutical, Inc.
Treatment for: Allergic Rhinitis

Marketing Status: Discontinued

AllerNaze, formerly Tri-Nasal (triamcinolone acetonide, USP) is a reformulated aqueous intranasal steroid nasal spray indicated for the once daily treatment of nasal symptoms associated with both seasonal and perennial allergic rhinitis in adults and children twelve years of age and older.

Development History and FDA Approval Process for AllerNaze

DateArticle
Jan  8, 2009Approval Collegium Pharmaceutical Announces FDA Approval of AllerNaze, a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis
Apr  8, 2008Collegium Pharmaceutical Announces FDA Filing for AllerNase, a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide